ADA in 30 Seconds: Competition for obesity drugs, clinical blind spots, and more

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

You’re reading the web edition of STAT’s ADA in 30 Seconds newsletter, from the American Diabetes Association’s annual conference. 

Welcome to the third and final edition of STAT’s ADA in 30 Seconds newsletter.

Elaine Chen starts us off with updates on the competitive climate for obesity drugs and I’m relaying insights on eating disorders, new word on a BCG vaccine, and a clarification from ADA on Friday’s police incident.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

View All Plans